Neuberger Berman Group’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15M Buy
145,642
+37,342
+34% +$2.43M 0.01% 784
2026
Q1
$5.15M Sell
108,300
-27,322
-20% -$1.22M ﹤0.01% 975
2025
Q4
$4.3M Sell
135,622
-25,552
-16% -$797K ﹤0.01% 1009
2025
Q3
$4.54M Buy
161,174
+40,755
+34% +$1.23M ﹤0.01% 986
2025
Q2
$4.43M Buy
120,419
+111,621
+1,269% +$3.86M ﹤0.01% 999
2025
Q1
$345K Buy
8,798
+49
+0.6% +$2.21K ﹤0.01% 1654
2024
Q4
$407K Hold
8,749
﹤0.01% 1576
2024
Q3
$395K Sell
8,749
-203
-2% -$9.66K ﹤0.01% 1587
2024
Q2
$441K Buy
+8,952
New +$365K ﹤0.01% 1525
2022
Q4
Sell
-6,474
Closed -$228K 1874
2022
Q3
$228K Buy
6,474
+36
+0.6% +$1.53K ﹤0.01% 1696
2022
Q2
$225K Buy
+6,438
New +$228K ﹤0.01% 1725
2022
Q1
Sell
-63,802
Closed -$4.87M 1982
2021
Q4
$4.87M Buy
63,802
+38,195
+149% +$3.92M ﹤0.01% 987
2021
Q3
$2.7M Buy
+25,607
New +$2.93M ﹤0.01% 1105

Other funds holding TWST

Neuberger Berman Group's TWST Position: Q2 2026 in Review

Neuberger Berman Group increased its Twist Bioscience (TWST) stake by 34% in Q2 2026, buying an estimated $2.43M and bringing the position to 145,642 shares worth $15M. The position accounts for 0.01% of the portfolio, ranked #784.

Neuberger Berman Group first reported a position in TWST in Q3 2021 and has held it in 13 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Neuberger Berman Group held 145,642 shares of Twist Bioscience worth $15M as of Q2 2026.
  • Neuberger Berman Group bought 37,342 Twist Bioscience shares in Q2 2026, an estimated $2.43M.
  • Twist Bioscience made up 0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #784 holding.
  • Neuberger Berman Group first reported a position in Twist Bioscience in Q3 2021 and has held it in 13 quarters since.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.